This inventor holds 2 USPTO granted patents. Top assignees: Hokuriku Pharmaceutical Co., Ltd., Hokuriku Seiyaku Co., Ltd.. Active years: 1994-1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994-1995
Title: Hiroyuki Sawanishi: Innovator in Pharmaceutical Compounds
Introduction
Hiroyuki Sawanishi is a notable inventor based in Kanazawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating allergic diseases. With a total of two patents to his name, his work has had a meaningful impact on medical science.
Latest Patents
Sawanishi's latest patents include innovative tricyclic compounds and methods for treating allergic diseases. One of his notable inventions is a pharmaceutical composition comprising piperazinealkanoic acid. This invention also includes novel polycyclic compounds represented by specific chemical formulas. These compounds are designed to serve as antiallergic agents and treatments for bronchial asthma. The patents detail methods for preparing these compounds and their pharmacologically acceptable salts.
Career Highlights
Throughout his career, Hiroyuki Sawanishi has worked with prominent companies in the pharmaceutical industry. He has been associated with Hokuriku Pharmaceutical Co., Ltd. and Hokuriku Seiyaku Co., Ltd. His work in these organizations has allowed him to focus on research and development in the field of allergy treatment.
Collaborations
Sawanishi has collaborated with esteemed colleagues, including Yasuo Ito and Hideo Kato. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Hiroyuki Sawanishi is a distinguished inventor whose work in pharmaceutical compounds has paved the way for new treatments for allergic diseases. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile